Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A1IR
|
|||
| Former ID |
DIB019691
|
|||
| Drug Name |
DABCO-C16
|
|||
| Synonyms |
TA279; C16-1,4-Diazabicyclo[2.2.2]octane
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C22H45N2+
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCCCC[N+]12CCN(CC1)CC2
|
|||
| InChI |
1S/C22H45N2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-24-20-16-23(17-21-24)18-22-24/h2-22H2,1H3/q+1
|
|||
| InChIKey |
YPKLQHHICPWJRD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated potassium channel Kv2.1 (KCNB1) | Target Info | Blocker (channel blocker) | [1] |
| Voltage-gated potassium channel Kv3.4 (KCNC4) | Target Info | Blocker (channel blocker) | [1] | |
| Reactome | Voltage gated Potassium channels | |||
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | ||||
| WikiPathways | Calcium Regulation in the Cardiac Cell | |||
| Potassium Channels | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 1,4-Diazabicyclo[2.2.2]octane derivatives: a novel class of voltage-gated potassium channel blockers. Mol Pharmacol. 2006 Mar;69(3):718-26. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.